Manufacturer record
Cipla Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
14 batches manufactured by Cipla Ltd (Goa) were declared Not of Standard Quality between May 2019 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 4C11469, Paracetamol and Domperidone Tablets (Dompar) (exp Nov 2027). DTL Konni (state lab) found it not of standard quality: Disintegration. Listed in the May 2026 alert.
Records by type
14 records linked to Cipla Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol and Domperidone Tablets (Dompar) | Batch 4C11469Mfg Dec 2024 · Exp Nov 2027 | DisintegrationDisintegration | DTL KonniState lab | May 2026 |
| Tamsulosin Hydrochloride & Dutasteride tab (Urimax-D | Batch 4GH0097Mfg Dec 2023 · Exp Nov 2025 | Negative for the presence of Tamsulosin Hydrochloride & DutasterideOther | State Drug Control & Research Lab, West BengalState lab | May 2025 |
| METFORMIN HYDROCHLOR IDE TABLETS IP (OKAMET- 500) | Batch 4O30069Mfg Feb 2024 · Exp Jan 2027 | Does not comply with respect to the Assay as per IP specificationAssay | PuducherryState lab | Dec 2024 |
| Tofacitinib Tablets IP 5 mg (TOFAJAK TABLETS) | Batch 4F30009Mfg May 2024 · Exp Apr 2026 | Identification and Assay of Tofacitinib citrate calculated as TofacitinibAssay | RDTL ChandigarhCDSCO lab | Nov 2024 |
| Tamsulosin and Dutasteride Tablets (Urimax-D) | Batch GH30334Mfg May 2023 · Exp Apr 2025 | Identification and Assay of Tamsulosin Hydrochloride, Dutasteride and Description.Assay | CDL KolkataCDSCO lab | Jul 2024 |
| Budesonide Nebuliser Suspension BP (Budecort Respules) | Batch SN30395Mfg Apr 2023 · Exp Mar 2025 | Assay of BudesonideAssay | CDL KolkataCDSCO lab | Jul 2024 |
| Tamsulosin Hydrochloride & Dutasteride Tablets (Urimax D) | Batch GH20067Mfg Jan 2022 · Exp Dec 2024 | Identification and Assay of Dutasteride and Assay of Tamsulosin HydrochlorideAssay | CDL KolkataCDSCO lab | Jul 2023 |
| Urimax D (Tamsulosin Hydrochloride & Dutasteride Tablets) | Batch GH20067Mfg Jan 2022 · Exp Dec 2023 | Identification & Assay of Tamsulosin Hydrochloride and Dutasteride The sample is deemed to be SpuriousAssay | CDL KolkataCDSCO lab | Apr 2023 |
| Atorvastatin & Aspirin Capsules (10 / 75) | Batch AAC1010Mfg Nov 2021 · Exp Oct 2023 | Dissolution of AtorvastatinDissolution | CDL KolkataCDSCO lab | Jan 2023 |
| Junior Lanzol 15 mg (Lansoprazole Orally Disintegrating Tablets 15 mg) | Batch BA12571Mfg Aug 2021 · Exp Jul 2023 | HardnessOther | CDTL MumbaiCDSCO lab | Dec 2022 |
| Acivir - 800 DT (Aciclovir Dispersible Tablets IP 800 mg) | Batch SN01674Mfg Oct 2020 · Exp Sep 2023 | Uniformity of DispersionUniformity of weight/content | CDL KolkataCDSCO lab | Oct 2021 |
| Acivir-200 DT (Aciclovir Dispersible Tablets I.P. 200 mg) | Batch SA91192Mfg Feb 2019 · Exp Jan 2022 | Uniformity of DispersionUniformity of weight/content | CDL KolkataCDSCO lab | Aug 2021 |
| Asthalin - 4 (Salbutamol Sulphate Tablet I.P. 4 mg) | Batch SA81637Mfg Apr 2018 · Exp Mar 2021 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Mar 2020 |
| Nitrofurantoin Capsules USP 100mg (URIFAST CAPSULES) | Batch BA82286Mfg Jul 2018 · Exp Jun 2020 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.